FDMT EPS Estimates
4D Molecular Therapeutics, Inc.
$12.14
-$0.73(-5.67%)
41
Overall
60
Value
20
Tech
44
Quality
Market Cap
$670.66M
Volume
794.53K
52W Range
$6.96 - $16.93
Target Price
$28.55
FDMT EPS estimates: the consensus estimate for 4D Molecular Therapeutics, Inc.'s current fiscal year is -$4.14 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
FDMT EPS Estimates
- EPS estimate, current quarter
- $-1.03
- EPS estimate, next quarter
- $-1.03
- EPS estimate, current year
- $-4.14
- EPS estimate, next year
- $-4.09
- EPS growth, 3-year
- +10.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.42 |
| 2024 | $-2.98 |
| 2023 | $-2.58 |
| 2022 | $-3.32 |
| 2021 | $-2.57 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FDMT | $12.14 | -5.7% | 794.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get 4D Molecular Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW